Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation

Acute posterior reversible encephalopathy syndrome (PRES) in setting of interferon-beta use: case presentation with reduction of edema in 72 h after cessation of interferon-beta therapy with sub-clinical inflammation

Abstract Background Posterior reversible encephalopathy syndrome (PRES) represents a transient change in mental status with associated vasogenic edema of cortical and subcortical brain structures. It is often attributed to multifactorial etiology including hypertension and altered hemodynamics and d...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nicholas Dietz, Zarmina Mufti, Muhammed Yousaf, Randal Brown, Christopher Counts, Martin F. Bjurström, Brian J. Williams, David Robertson
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Interferon
Multiple sclerosis
Hypertension
Posterior reversible encephalopathy syndrome
Seizure
Case report
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/f9730d8944384865afd777ad19ebc271
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/f9730d8944384865afd777ad19ebc271

Ejemplares similares